What Would You Do With a $10,000 Genome?
Our newly developed grant program for genome biology and technology was designed to develop new therapies for the world’s most pressing diseases more
In order to inspire new scientific approaches that employ advanced genomic technologies, Life Technologies created a “What Would You Do With a $10,000 Genome?” grant program in 2009. During the 10th annual Advances in Genome Biology and Technology meeting, Dr. Charles Mullighan, MD, PhD, of St. Jude Children’s Research Hospital, was awarded the inaugural prize.
Dr. Mullighan was selected from more than 200 entries based on his interest in using a next-generation sequencing approach to identify potential new therapies to treat acute lymphoblastic leukemia, a cancer of white blood cells that affects one in 29,000 children each year. Dr. Mullighan proposed to use the SOLiD™ 3 System to explore new treatment options for the 15 percent of children who relapse each year, of whom only 30 percent will survive five years.
Charcot-Marie-Tooth Disease (CMT)
Enabling scientist to more deeply understand the spectrum of disease more
For Dr. James Lupski, Cullen Professor and Vice Chair for the Department of Molecular and Human Genetics at Baylor College of Medicine in Houston, the scientific quest is intensely personal. Dr. Lupski has Charcot-Marie-Tooth Disease (CMT), as do three of his siblings.
CMT is one of the most common inherited neurological diseases, affecting one in 2,500 people in the United States. For the past 20 years, Dr. Lupski has been searching for the genetic mutation causing this disease. In March 2010 he and his partner, Dr. Richard Gibbs, announced in the New England Journal of Medicine that they had found it.
Lupski and Gibbs used the SOLiD® System, a next generation genomic analysis platform, to identify the key DNA mutations connected to his type of CMT. Through this collaboration between Life Technologies and Baylor College, scientists now can apply this methodology to the discovery of rare genetic variants in more than 12,000 other genetic diseases.
Life Technologies is at the forefront of this pioneering enterprise. We are enabling scientists worldwide to more deeply understand the spectrum of disease by equipping them with rapidly evolving tools, and we are closing the gap between research and treatment by fully engaging with physicians in the clinical setting. Together, we are furthering the quest to make mass personalized medicine a reality.
We are taking steps towards synthetic biology as a solution for renewable energy more
Life Technologies and SG Biofuels, Inc., a bioenergy crop company, used the SOLiD® 4.0 System to sequence the Jatropha curcas genome, advancing the development of this oilseed-producing crop as a source for biofuel. Resistant to drought and pests and able to thrive in locations not desirable for food crops, these oil-packed, nonedible seeds are a high-yielding and low-cost source as feedstock substitutes for diesel, petrochemical, and jet fuel industries.
Algae has enormous potential not only to diminish our reliance on petroleum as a fuel, but to effectively sequester carbon as well. more
Today, the process of converting algae to biofuel is energy-intensive and expensive, but the US Department of Energy and a group of industry partners that includes Life Technologies is exploring synthetic biology as a way to create affordable and plentiful algae-based biofuels. In 2010 the group pledged a total of $12 million to create a Consortium for Algal Biofuels Commercialization. The goal of the program is to develop new genetic and molecular technologies that can improve algal fuel production, as well as new approaches for recycling nutrients and technologies for producing crops. Life Technologies is contributing sequencing capabilities via the SOLiD® 4 System, and also creating kits with vectors, media, and reagents needed for algae research.
Cold cases, missing persons, exonerations and historical and archeological cases... our new forensics kits are shaping a new era of efficiency and effectiveness for forensic DNA laboratories. more
In 1983, Kenny Waters was convicted of a murder he did not commit. His sister, Betty Anne, spent two decades working to set him free. After 18 years in prison, DNA testing of a blood sample exonerated Kenny. The moving story of Kenny’s survival and Betty Anne’s perseverance is the subject of Conviction, a feature film produced by the Innocence Project, starring Academy Award winner Hilary Swank.
The Innocence Project is a national litigation and public policy organization dedicated to exonerating wrongly convicted people through DNA testing, and reforming the criminal justice system to prevent future injustice. To date, DNA results have freed more than 250 people from incarceration for crimes they did not commit. Life Technologies was a proud sponsor of Conviction and applauds the efforts of the Innocence Project. Together, we are committed to developing the most cutting-edge tools to help solve and prevent a wide variety of crimes, to contribute to public safety and security, and to exonerate the wrongly convicted.
Seeking to understand the cause of this complex disease more
Life Technologies and EdgeBio are partnering with researchers at Virginia Commonwealth University (VCU) to study the impact of gene regulation in the development of schizophrenia. The project is using the SOLiD® System and MethylMiner™ Methylated DNA Enrichment Kit to search for methylation patterns associated with schizophrenia in the hope of better understanding the cause of this complex disease.
The first study to decipher the cause of a dominant human disease more
New research published in Nature Genetics sheds light on Schinzel-Giedion, an extremely rare and fatal disorder with only 50 diagnosed cases worldwide. Children with Schinzel-Giedion usually do not survive past the age of ten. Geneticists from the Radboud University Nijmegen Medical Center (RUNMC) in The Netherlands used the Life Technologies SOLiD® System to pinpoint the disease’s cause: a spontaneous mutation in a parent’s germ cell line, in a gene called SETBP1. This is the first study to decipher the cause of a dominant human disease by sequencing the protein-coding sections of the human genome (exome).
Donating our instruments to diagnose ASD more
A team led by Dr. Stephen Scherer at The Hospital for Sick Children (SickKids) was granted $8.9 million from the Global Leadership Round in Genomics & Life Sciences in Canada to study the genomic basis of ASD.
The project, called “Autism Spectrum and Associated Neurodevelopmental Disorders: Genomes to Outcomes,” is geared toward developing cutting-edge technologies to diagnose ASD and other neurological disorders. Scientists currently are using this technology to sequence genes from thousands of ASD patients in Ontario. It is the largest study of its kind. Life Technologies donated a $700,000 next generation SOLiD® system to the project.
Providing expertise for testing in preclinical research concepts more
Life Technologies, the University of California, San Diego, and The Salk Institute for Biological Studies have initiated studies for the development of cell transplant therapy for amyotrophic lateral sclerosis (ALS). Currently there is only one FDA-approved pharmaceutical addressing this lethal disease, which affects approximately 30,000 people in the United States.
Life Technologies is providing support through its expertise in stem cell biology, cell separation, next-generation sequencing, and bioproduction, to help teams test their preclinical research concepts.
DNA analysis holds the potential for accurate diagnosis more
Twins Alexis and Noah Beery suffered from dopa-responsive dystonia, a hard-to-diagnose movement disorder that causes the muscles to contract and spasm involuntarily. The twins were not diagnosed until the age of 5. Now, at age 13, after enduring years of physical and emotional pain, they have found life-altering treatment. The twins’ father was so inspired by the potential of DNA analysis to help his children and others with similar struggles that he came to work for Life Technologies.
“We spent five-and-a-half years searching for what is actually a relatively simple problem to solve. During those years, there is nothing I would not have done as a parent to make them more comfortable and to get them where they are today. And I think in sequencing, having the ability to identify this problem right after birth would have been…life changing …”
--Joe Beery, Chief Information Officer
Preserving Biodiversity: Cheetah Conservation in Namibia
Cheetahs are highly susceptible to disease and reproductive health problems. DNA tools from Life Technologies are helping boost the population more
Cheetahs are a unique breed of cat. Approximately 99 percent of their genes are identical, a biologically significant fact given that in most mammalian species only 80 percent of the genes in related individuals are identical. This lack of variation compromises the big cat’s ability to adjust to sudden environmental changes. Thus, cheetahs are highly susceptible to certain viruses and reproductive health problems. Today, only 10,000 wild cheetahs exist globally.
The middle of African bush country might seem like an unlikely place for a high-tech DNA laboratory, but with 20 percent of the world’s free-ranging cheetah population living in Namibia, it's the perfect place to develop the tools needed to save this endangered population. In 2009, we invested in the founding of the Applied Biosystems Genetic Conservation Laboratory, located at the headquarters of the Cheetah Conservation Fund (CCF) in Otjiwarongo, Namibia. Here, four scientists and 50 international course participants have been trained on advanced genomic analysis technology and have developed a noninvasive genetic monitoring program, using Life Technologies genetic analysis systems and reagents as tools in their work to accurately characterize the population of cheetahs in Namibia and other home-range countries. Scientists are not only tracking the cats but are working to answer questions such as how cheetah genes transfer from one population to another, in order to identify geographical patterns of genetic variation and to study the animals’ behavior in specific habitats. This partnership is designed to further our knowledge of biodiversity on a larger scale, with a goal of giving us the knowledge we need to reverse negative trends in species loss.
DNA sampling could reunite families separated by natural disasters. more
“What makes Life Technologies and our industry particularly exciting is that we can meaningfully contribute to improving the human condition by the work that we do over an extended period of time. I see the [Haiti earthquake] relief fund as an opportunity to act upon that same aspiration today …”
--Nicholas Barthelemy, President of the Cell Systems Division, Life Technologies
In addition to a significant financial contribution from its Foundation, Life Technologies is deploying sequencing technologies for the DNA PROKIDS project in Haiti.
Using cutting-edge sequencing technologies, the DNA PROKIDS program allows Haitian officials to take samples of genetic data from 6,000 adults who have reported missing children, from immediate relatives with a blood relationship, and from children with no family or doubtful relatives. The aim is to help reunite abducted and homeless children with their parents after the devastating earthquake.
The process will fulfill all warranties and quality requirements in sample chain of custody and data analysis and delivery, ensuring that families who can be reunited will be reunited.
Providing support know-how for those working in the lab brings better results. more
The market for real-time PCR instruments and reagents is a relatively mature one where Life Technologies already holds a substantial position. In 2009, the challenge was growing this market by redefining how we think about our customers, our business and how we work together.
Using the UCI process and starting with observing customers as users, the product team learned that customers need more than innovative products; they need a “great colleague in the lab” to guide them in the use of technology. As they learn and use the technology, their needs evolve and change.
The need for connection is greatest for researchers who are just learning the technology and looking for guidance. It drops off with intermediate users, who are fairly confident with the technology and need only residual support, and rises again for experts who want to share their knowledge with others and collaborate. These findings did not always correlate to the way Life Technologies interacted with researchers. Our practices were not evolving with our customers needs.
The project team created a model of contact and connection that would best fit the user’s level of expertise. This was achieved by using a web-based tool for researchers so they could easily find necessary information to plan and troubleshoot experiments based on their experience level.
While these concepts are still being tested and refined, feedback from users during prototyping has been very positive.
African Bushman experiment leads the way to more effective drugs. more
One challenge for the pharmaceutical community globally is to develop drugs that are effective for individual populations. Life Technologies aides in this endeavor; a breakthrough in South Africa has revealed new and surprising diversity within the human genome, and demonstrated how interconnected individuals are to one another.
A Southern African Bushmen collaborative project involved the whole-genome sequencing of two named individuals: !Gubi, a Kalahari Bushman, and Archbishop Desmond Tutu. This project had some surprising results.
By characterizing the genetic variations that are present in Southern African genomes, better drugs (such as anti-viral drugs for HIV) can be generated that are useful for specific populations. This project represents an important first step toward this goal.
Promoting intellectual property speeds invention. more
At Life Technologies, we make the development of new Intellectual Property (IP) a central theme across our business. Each year we spend more than $300 million on research and development—more than any other life sciences tools company. This investment has resulted in a library of more than 3900 patents.
We track new inventions closely; anyone can submit an invention disclosure at any time, and all submissions are reviewed. In fact, we recently implemented an online tool to enable an invention disclosure to be submitted and modified across the company in a cumulative fashion. We believe that tracking the number of invention disclosures is a reasonable proxy for measuring innovation coming out of our R&D teams; we review our progress monthly.
We also provide performance incentives for innovation, and our R&D teams have specific goals and objectives designed around this metric. In 2009 we reworked our IP incentive effort so that inventors will benefit when their creation delivers real value for the company. Each year we invite key innovators to a dedicated Board of Directors dinner.
How each employee has the power to drive success. more
To kick off in 2009, more than 250 members of the Life Technologies senior management team attended the two-day Global Leadership Meeting (GLM) in San Diego. The meeting’s theme, “The Power of One,” reflected not only the power of the combined Invitrogen and Applied Biosystems organization to shape scientific discovery and improve the quality of life, but also the power that each employee has to move the company toward its goals. This meeting was a chance for us to share our purpose, our values and our plans for the upcoming year.
Each participant made a commitment to cascade the information and insights from the GLM to his or her team. Each and every Life Technologies employee should understand our overall purpose, goals and objectives and more importantly, how his or her work will contribute to our shared success.
User-Centered Innovation Drives a New Intranet Solution
How social networking will help boost scientific connections. more
Leveraging the power and effectiveness of social networking can be key in driving better connection, communication and collaboration at Life Technologies.
Initially, the IT team was charged with building a new intranet solution that would help Life Technologies employees—give them relevant information and enable them to share and network through the latest in web 2.0 technology. We interviewed software firms, brainstormed ideas on how the intranet should be constructed, set up committees, and spent months planning a solution… but were we just creating another solution like the previous one? That’s when User Center Innovation helped us change the paradigm.
Instead of designing what we thought our employees wanted, we asked them. Three key “wants” emerged: employees want to connect, communicate and collaborate. The resulting discovery process led us to determine that a social networking site—one that takes the best of social media and tailors it to Life Technologies culture—would best meet all of the needs. As a result of in the work completed in 2009, a new internal social networking platform will launch later in 2010.
Public service leads to better team building. more
When Life Technologies first Global Quality Leadership Team Meeting was held in San Diego, California, last year, the group was pleasantly surprised to find out that the meeting’s typical get-to-know-you team-building exercise would also be a public service project. Forty-two individuals from around the world visited the San Diego Food Bank and broke into two competitive teams. Working together to understand each other's strengths, communicating, encouraging each other and using their quality experiences to visually inspect and sort food produced a successful outcome—for our employees and for the food bank. In less than 2 hours, the two teams sorted 9,000 pounds of food, enough to feed 100 people for 18 days. The success of this service project inspired other teams to follow suit.
How the ocean is helping inspire and empower the disadvantaged young. more
When you live alongside the rich marine environment of the Pacific Ocean, it’s only natural to look to the ocean as your teacher. That’s what the Ocean Discovery Institute has done, and Life Technologies supports this nonprofit organization’s programs with funding, in-kind donations of scientific equipment and supplies and the participation of our scientists. The Ocean Discovery Institute runs tuition-free educational programs for 5,000 urban, disadvantaged and minority youths each year, using science, the ocean and nature to inspire and empower them. The mix of classroom-based experimental science, intensive after-school and summer programs, and community-based habitat restoration provides more than 48,000 hours of instruction annually.
Each year, the top 20 to 28 students in the Ocean Discovery Institute are invited to join its Ocean Leaders program. This intensive course includes 11 weeks training and preparation in San Diego, five weeks working on actual research projects at the Vermillion Sea Field Station on Bahía de Los Angeles in Baja California, and three weeks debriefing and presenting their results. The field station is located among 17 nature-rich islands in the Sea of Cortez along Baja’s eastern coast, about 450 miles south of San Diego.
In 2009, Life Technologies sent Associate Scientist Tatiana Cirico from the Genomic Technologies group in Molecular Biology Systems to the Bahía site to introduce the students to DNA, cloning and protein expression. “I wanted to link the talk to the subjects they were studying,” Cirico says, “so I described the fluorescent proteins we use as markers in cell biology and related them to the bioluminescence exhibited by many marine organisms.” For a hands-on experiment, Cirico conducted an experiment in which the students extracted DNA from strawberries using simple household chemicals. “That was exciting for them,” she says. “The solution was even pink!”
As we build new spaces or renovate our existing buildings, we have adopted the Leadership in Energy and Environment Design (LEED) program from the U.S. Green Building Council as a standard. more
In 2009, the company’s new Shanghai Demonstration Laboratory earned LEED Gold Certification. This facility has demonstrated a whole-building approach to sustainability by recognizing performance in five key areas of human and environmental health: energy savings, water efficiency, CO2 emissions reduction, improved indoor environmental quality, and stewardship of resources.
Highlights from the LEED checklist include:
In 2003, the Pleasanton, California site became the first Life Technologies site to be awarded a LEED building certification, earning its Silver certification in the early days of the formal LEED program. Our headquarters in Carlsbad, California and buildings under construction in Scotland and China are targeted for certification in 2010.